Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HRS-1780 tablets and Henagliflozin Proline tablets in chronic kidney disease
CTR20240132Phase 2Completed
- Sponsor
- Shandong Sende
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-1780 in chronic kidney disease (CKD), sponsored by Shandong Sende. Started Jan 2024; status: completed.
02
Drugs
HRS-1780
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on CTR20240132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240132.